HS
ETON icon

HighVista Strategies’s Eton Pharmaceutcials ETON Stock Holding History

HighVista Strategies’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,517
Closed -$109K – 84
2021
Q3 		$109K Buy
21,517
+10,884
+102% +$56.6K 0.07% 91
2021
Q2 		$65K Buy
+10,633
New +$78.8K 0.05% 111

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighVista Strategies's ETON Position: Q4 2021 in Review

HighVista Strategies sold out of Eton Pharmaceutcials (ETON) in Q4 2021, closing a stake of 21,517 shares — an estimated $109K sold.

HighVista Strategies first reported a position in ETON in Q2 2021 and held it in 2 quarters. The position peaked at $109K in Q3 2021. 32 funds tracked by Wall St. Rank hold ETON as of Q4 2021.

  • HighVista Strategies reported no remaining Eton Pharmaceutcials position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 21,517 Eton Pharmaceutcials shares in Q4 2021, an estimated $109K.
  • HighVista Strategies first reported a position in Eton Pharmaceutcials in Q2 2021 and held it in 2 quarters.
  • HighVista Strategies's Eton Pharmaceutcials position peaked at $109K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.